Hyperaldosteronism

PHILADELPHIA — Obesity-associated dysregulated aldosterone is an endotype predictive of response to lorundrostat for patients with uncontrolled or treatment-resistant hypertension, according to data presented at ASN Kidney Week.

In this video exclusive, Jonathan D. Leffert, MD, talks with Richard J. Auchus, MD, PhD, FACE, about how to define primary hyperaldosteronism, the importance of screening and tips for treating the disease.

The problem of hypertension is a multifaceted one. Many factors contribute to the increasing global burden of hypertension. Cardiology Today asked some of the nation’s leading experts on hypertension to glean their thoughts on the most critical issues facing patients and clinicians in that area.